Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Eskalith (lithium carbonate) Capsules and Eskalith CR (lithium carbonate) Controlled Release Tablets, SmithKline Beecham NDA 16-860/S-073, 17-971/S-019 & 18-152/S-017 Lithium Carbonate Capsules & Syrup, Roxane, NDA 17-812/S23 & 18-421/ S21 1/31/03 2/12/03 Lithium Carbonate Capsules, USP, 150, 300 and 600 mg, Roxane, NDA 17-812/SCP-021 6/14/01 11/25/02 Lithium Carbonate Capsules & Lithium Citrate Syrup, Roxane, NDA 17-812/S-011, S-013, S-014, S-016 & S-017 & 18-421/S-011, S-013, S-014, S-015, S-016 11/26/01 2/12/02 Lithium Carbonate Capsules & Controlled Release Tablets, SmithKline Beecham NDA 16-860/S59, S65, S67, S68, S69, S72 & 18-152/S3, S8, S10, S12, S13, S16 5/8/02 5/16/02 Lithium Carbonate Tablets ER, 450 mg, Barr ANDA 76-366 8/21/03 Lithium Carbonate Capsules USP, 150 mg, West-ward Pharmaceutical Corp. ANDA 76-243/S1 2/24/03 Lithium Carbonate Capsules USP, 300 mg, West-ward Pharmaceutical Corp. ANDA 76-243 6/27/02 Lithium Carbonate Capsules USP, 300 mg, Able, ANDA 76-121 9/27/01 4/16/03 Lithium Carbonate Extended-Release Tablets USP, 300 mg, Able ANDA 76-382 4/21/03 Lithium Carbonate Extended-Release Tablets USP, 300 mg, Barr, ANDA 76-170 LITHIUM CARBONATE Capsule; 300MG LITHIUM CARBONATE Able 016860 LITHIUM CARBONATE Capsule; 300MG ESKALITH GLAXOSMITHKLINE 017812 LITHIUM CARBONATE Capsule; 150MG LITHIUM CARBONATE Roxane 017812 LITHIUM CARBONATE Capsule; 300MG LITHIUM CARBONATE Roxane 017812 LITHIUM CARBONATE Capsule; 600MG LITHIUM CARBONATE Roxane 076243 LITHIUM CARBONATE Capsule; 150MG LITHIUM CARBONATE West Ward 076243 LITHIUM CARBONATE Capsule; 300MG LITHIUM CARBONATE West Ward 076382 LITHIUM CARBONATE Tablet, Extended Release; 300MG LITHIUM CARBONATE Able 076170 LITHIUM CARBONATE Tablet, Extended Release; 300MG LITHIUM CARBONATE Barr 076366 LITHIUM CARBONATE Tablet, Extended Release; 450MG LITHIUM CARBONATE Barr 018152 LITHIUM CARBONATE Tablet, Extended Release; 450MG ESKALITH CR GLAXOSMITHKLINE 018027 LITHIUM CARBONATE Tablet, Extended Release; 300MG LITHOBID SOLVAY 076490 LITHIUM CARBONATE Tablet, Extended Release; 450MG LITHIUM CARBONATE West Ward 016834 LITHIUM CARBONATE Tablet; 300MG LITHIUM CARBONATE PFIZER 018558 LITHIUM CARBONATE Tablet; 300MG LITHIUM CARBONATE Roxane 070755 LITHIUM CITRATE Syrup; 300MG CARBONATE/5ML LITHIUM CITRATE Morton Grove 018421 LITHIUM CITRATE Syrup; 300MG CARBONATE/5ML LITHIUM CITRATE Roxane Eskalith (lithium carbonate) Capsules, Tablets & CR Tablets, GlaxoSmithKline Lithium Carbonate Capsules, Able Laboratories, Inc. Approval | Lithium Carbonate Extended-Release Tablets, Roxane Labs, Approval | Lithium Carbonate Capsules, Apotex, Approval | Lithobid (Lithium Carbonate) Slow-Release Tablets, JDS Pharma, Labeling Revision | Lithobid (lithium carbonate, USP) Extended-Release Tablets, JDS Pharmaceuticals, Labeling Revision | Lithium Carbonate Extended-Release Tablets, Westward Pharma, Control Supplement | Lithium Carbonate Capsules, West-Ward Pharma, Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com